Lin, T., Al-Makki, A., & Shepler, B. (2022). Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease. Journal of Pharmacy & Pharmaceutical Sciences, 25, 77–83. https://doi.org/10.18433/jpps32284